ConductScience.org, home

Paper42440705

A multi-mineral intervention is associated with improved intestinal permeability in patients with ulcerative colitis: results from a pilot trial.

Aslam MN and 5 others. Front Med (Lausanne), 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. A multi-mineral intervention is associated with improved intestinal permeability in patients with ulcerative colitis: results from a pilot trial. Papers, record 42440705. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42440705

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A multi-mineral intervention is associated with improved intestinal permeability in patients with ulcerative colitis: results from a pilot trial.
PubMed
Journal
Front Med (Lausanne)
PubMed
Year
2026
PubMed
Publication types
Clinical Trial, Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-08-13
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Aslam MNMuhammad N
2Turgeon DKDanielle Kim
3McClintock SShannon
4Allen RRon
5Sen AAnanda
6Varani JJames

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Trials2

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT03869905Aquamin® as an Adjuvant Intervention for Ulcerative ColitisBackgroundClinicalTrials.gov
NCT04855799GI Permeability Change in Response to Aquamin®Derived from the trialYesClinicalTrials.gov

Download CSV of trials

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Update of41646788A Multi-Mineral Intervention Improves Intestinal Permeability in Patients with Ulcerative Colitis: Results from a 90-Day Pilot Trial.https://conductscience.org/library/papers/41646788

Source PubMed

Download CSV of comments and corrections

References58

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
118566104C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.Gut2008https://conductscience.org/library/papers/18566104PubMed
28725259Intestinal permeability in exocrine pancreatic insufficiency due to cystic fibrosis or chronic pancreatitis.Pediatr Res1996https://conductscience.org/library/papers/8725259PubMed
335634402Liver Protein Expression in NASH Mice on a High-Fat Diet: Response to Multi-Mineral Intervention.Front Nutr2022https://conductscience.org/library/papers/35634402PubMed
434204044Advances in Intestinal Barrier Preservation and Restoration in the Allogeneic Hematopoietic Cell Transplantation Setting.J Clin Med2021https://conductscience.org/library/papers/34204044PubMed
520725949Importance of disrupted intestinal barrier in inflammatory bowel diseases.Inflamm Bowel Dis2011https://conductscience.org/library/papers/20725949PubMed
627106638Intestinal Alkaline Phosphatase Regulates Tight Junction Protein Levels.J Am Coll Surg2016https://conductscience.org/library/papers/27106638PubMed
730115904Mechanisms regulating intestinal barrier integrity and its pathological implications.Exp Mol Med2018https://conductscience.org/library/papers/30115904PubMed
821782616
Monolayers of IEC-18 cells as an in vitro model for screening the passive transcellular and paracellular transport across the intestinal barrier: comparison of active and passive transport with the human colon carcinoma Caco-2 cell line.
Environ Toxicol Pharmacol2002https://conductscience.org/library/papers/21782616PubMed
927851786Calcium Reduces Liver Injury in Mice on a High-Fat Diet: Alterations in Microbial and Bile Acid Profiles.PLoS One2016https://conductscience.org/library/papers/27851786PubMed
1031558743Structural insight into glucose repression of the mannitol operon.Sci Rep2019https://conductscience.org/library/papers/31558743PubMed
1132213701Intestinal alkaline phosphatase targets the gut barrier to prevent aging.JCI Insight2020https://conductscience.org/library/papers/32213701PubMed
1230837784Primary sclerosing cholangitis and inflammatory bowel disease comorbidity: an update of the evidence.Ann Gastroenterol2019https://conductscience.org/library/papers/30837784PubMed
1340067071Intestinal Permeability In Vivo in Patients With Inflammatory Bowel Disease: Comparison of Active Disease and Remission.Inflamm Bowel Dis2025https://conductscience.org/library/papers/40067071PubMed
1427366227The intestinal microbiome, barrier function, and immune system in inflammatory bowel disease: a tripartite pathophysiological circuit with implications for new therapeutic directions.Ther Adv Gastroenterol2016https://conductscience.org/library/papers/27366227PubMed
1528316376The Role of Intestinal Alkaline Phosphatase in Inflammatory Disorders of Gastrointestinal Tract.Mediators Inflamm2017https://conductscience.org/library/papers/28316376PubMed
1620150219A mineral-rich red algae extract inhibits polyp formation and inflammation in the gastrointestinal tract of mice on a high-fat diet.Integr Cancer Ther2010https://conductscience.org/library/papers/20150219PubMed
1710329946Physiological significance of volume-regulatory transporters.Am J Physiol1999https://conductscience.org/library/papers/10329946PubMed
1822222483A multi-mineral natural product inhibits liver tumor formation in C57BL/6 mice.Biol Trace Elem Res2012https://conductscience.org/library/papers/22222483PubMed
1911785714Intestinal permeability in Crohn's disease patients and their first degree relatives.Dig Liver Dis2001https://conductscience.org/library/papers/11785714PubMed
2035360746Cell-Matrix Interactions Contribute to Barrier Function in Human Colon Organoids.Front Med (Lausanne)2022https://conductscience.org/library/papers/35360746PubMed

See all 58 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42440705

GET https://conductscience.org/api/papers/v1/42440705/references?page=2